CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +27,567 | 109,080 | ||
| 2019-03-05 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −8,408 | $3.61 | $30K | 100,672 |
| 2019-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −27,567 | 55,133 | ||
| 2018-03-10 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +20,434 | 87,166 | ||
| 2018-03-10 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −5,653 | $4.51 | $25K | 81,513 |
| 2018-03-10 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −20,434 | 40,866 | ||
| 2018-03-09 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +25,000 | 73,628 | ||
| 2018-03-09 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −6,896 | $4.51 | $31K | 66,732 |
| 2018-03-09 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −25,000 | 25,000 | ||
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +8,333 | 51,443 | ||
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −2,815 | $4.29 | $12K | 48,628 |
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −8,333 | 0 | ||
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Grant or award · Common Stock Option | +126,500 | 126,500 | ||
| 2018-03-05 | Bagarazzi Mark Chief Medical Officer | Grant or award · Restricted Stock Unit | +82,700 | 82,700 | ||
| 2017-03-10 | Bagarazzi Mark Chief Medical Officer | Grant or award · Common Stock Options | +100,000 | $6.68 | $668K | 100,000 |
| 2017-03-10 | Bagarazzi Mark Chief Medical Officer | Grant or award · Restricted Stock Unit | +61,300 | 61,300 | ||
| 2017-03-09 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion | +25,000 | 50,758 | ||
| 2017-03-09 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −7,648 | $6.61 | $51K | 43,110 |
| 2017-03-09 | Bagarazzi Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −25,000 | 50,000 | ||
| 2017-03-06 | Bagarazzi Mark Chief Medical Officer | Shares withheld for taxes | −3,067 | $6.95 | $21K | 25,758 |
Page 1 of 2 · 22 trades